Home / Tocilizumab / Italy
IT ATC L04AC07 · updated 2 Nov 2026
Tocilizumab shortage in Italy
Is there a Tocilizumab shortage in Italy?
Yes. As of 2 Nov 2026, 4 Tocilizumab products are reported short in Italy, the first since 19 Aug 2024. No return date has been given. Main reason: increased demand.
Also short in Canada, Austria, Czechia, Japan. All countries.
Affected products in Italy
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | TYENNE | FRESENIUS KABI DEUTSCHLAND GMBH | 19 Aug 2024 | not given | Increased demand Elevata richiesta |
| IT | TYENNE | FRESENIUS KABI DEUTSCHLAND GMBH | 29 Aug 2024 | not given | Increased demand Elevata richiesta |
| IT | TYENNE | FRESENIUS KABI DEUTSCHLAND GMBH | 8 May 2026 | not given | Manufacturing problem Problemi produttivi: ridotta disponibilità |
| IT | TYENNE discontinuation | FRESENIUS KABI DEUTSCHLAND GMBH | 31 Aug 2026 | not given | Manufacturing problem Problemi produttivi |
Source
AIFA (Italian Medicines Agency), licensed CC-BY 4.0. Official list. All shortages reported by marketing-authorisation holders, including medicines being withdrawn.